+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 75Years
All Genders
ID06360120

Study of Clopidogrel Combined With Atorvastatin or Rosuvastatin for Treating Large-vessel Ischemic Stroke in Adults Aged 18 to 75

Led by Kafrelsheikh University · Updated on 2025-09-05

600

Participants Needed

1

Research Sites

3 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the impact of adding atorvastatin or rosuvastatin within the first 24 hours to clopidogrel treatment in patients experiencing their first large-vessel ischemic stroke. This trial aims to assess clinical outcomes using stroke severity and disability scales, along with monitoring for possible side effects. The study is a randomized controlled trial conducted by Kafrelsheikh University and focuses on patients aged 18 to 75 years. Participants are divided into two groups one group receives 40 mg of atorvastatin daily along with clopidogrel, and the other group receives 20 mg of rosuvastatin daily with the same clopidogrel regimen. Both statins are given for three months, while clopidogrel is started with a 300 mg loading dose followed by 75 mg daily for the entire treatment period. The trial includes clinical assessments, imaging scans, blood tests, and heart monitoring to evaluate stroke effects and safety. During the study, patients undergo evaluations including the National Institute of Health Stroke Scale NIHSS at admission and day 7, and the Modified Rankin Scale mRS at one week and three months. Imaging tests include CT and MRI brain scans with stroke protocols and vascular assessments. Blood tests check liver function, inflammation, and muscle enzymes to monitor for adverse effects. The main outcome is the rate of new strokes at 90 days, with additional measures of stroke severity, functional recovery, cardiovascular events, and drug safety over the three-month period.

CONDITIONS

Brief Title

Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

Research Team

M

mohamed G. Zeinhom, MD

S

sherihan R. ahmed, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here